ទំព័រដើម › ជំងឺ Crohn › នូវយ៉ាក › New York City
ការសាកល្បងគ្លីនិកសម្រាប់ ជំងឺ Crohn នៅក្នុង New York City, NY
ការសិក្សាចំនួន 35 សម្រាប់ ជំងឺ Crohn កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ New York City (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
កំពុងជ្រើសរើសដំណាក់កាល 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
កំពុងជ្រើសរើសដំណាក់កាល 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
កំពុងជ្រើសរើសដំណាក់កាល 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
កំពុងជ្រើសរើសដំណាក់កាល 3
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- New York Gastroenterology Associates ( Site 5013), New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
កំពុងជ្រើសរើសដំណាក់កាល 4
- New York Gastroenterology Associates, New York
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- New York Gastroenterology Associates, New York
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- Lenox Hill Hospital, New York
- និង 1 ទៀត
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
កំពុងជ្រើសរើសដំណាក់កាល 3
- New York Gastroenterology Associates, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- Columbia University Medical Center-Site Number: 8400138, New York
- និង 2 ទៀត
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- New York Gastroenterology Associates-Site Number: 8400009, New York
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 4
- NYU Langone Health, New York
Standardized Microbiota Transplant Therapy in Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- NYU Langone Health, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- New York Gastroenterology Associates, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Weill Cornell Medicine, New York
Behavioral Therapy for Crohn's Disease
កំពុងជ្រើសរើស
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
កំពុងជ្រើសរើស
- NYU Langone Health, New York
- Cornell University, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Icahn School of Medicine at Mount Sinai, New York
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
កំពុងជ្រើសរើសដំណាក់កាល 3
- New York Presbyterian Hospital, New York
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 3
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 4
- Columbia University Medical Center, New York
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
កំពុងជ្រើសរើស
- Weill Cornell Medical College, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Mirador Therapeutics Selected Site, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Icahn School of Medicine at Mount Sinai, New York
Treatment of Moderate to Severe Refractory Crohn's Disease
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Mount Sinai Health Systems, New York
Helmsley 3.0: Abbreviated MRE
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- NYU Langone, New York
ការសាកល្បងសម្រាប់ ជំងឺ Crohn នៅក្នុងទីក្រុងផ្សេងទៀត
- Boston, MAការសិក្សា 19
- Miami, FLការសិក្សា 19
- Cleveland, OHការសិក្សា 19
- St. Louis, MOការសិក្សា 19
- Tyler, TXការសិក្សា 17
- Houston, TXការសិក្សា 17
- Orlando, FLការសិក្សា 17
- Atlanta, GAការសិក្សា 17
- San Antonio, TXការសិក្សា 15
- San Diego, CAការសិក្សា 15
- Los Angeles, CAការសិក្សា 15
- Colorado Springs, COការសិក្សា 13
ការសិក្សាផ្សេងទៀតនៅក្នុង New York City
- មហារីកទ្រូងការសិក្សា 136
- Non-Small Cell Lung Cancerការសិក្សា 121
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 109
- មហារីកតូចការសិក្សា 103
- មហារីកដែលរីករាលដាលការសិក្សា 93
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 78
- មហារីកស៊ុតការសិក្សា 69
- មហារីកសួតការសិក្សា 60
- ជំងឺ Multiple Myelomaការសិក្សា 60
- មហារីកតំបក់ការសិក្សា 60
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 52
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 51
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។